[Prevention of the respiratory distress syndrome of the newborn. Value of antepartum treatment with glucocorticoids].
D000420:Albuterol / Q000627:therapeutic use; D001034:Apgar Score; D001623:Betamethasone / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D005865:Gestational Age; D006801:Humans; D006819:Hyaline Membrane Disease / Q000517:prevention & control; D007231:Infant, Newborn; D008297:Male; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011248:Pregnancy Complications; D012127:Respiratory Distress Syndrome, Newborn / Q000401:mortality / Q000517:prevention & control*
D001623:Betamethasone; D000420:Albuterol
Prévention du syndrome de détresse respiratoire chez le prématuré. Intérêt du traitement antepartum par les glucocorticoïdes